Features Screener Stocks Charts
Sign In Sign Up

RPG Life Sciences Limited Cash Flow Statement

NSE:RPGLIFE | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

Cash Flow Insights

Cash Conversion

0.33x

RPGLIFE's operating cash flow was significantly below net income in FY 2025, suggesting earnings include substantial non-cash items.

Free Cash Flow

₹418.30M

RPGLIFE's free cash flow was ₹418.30M in FY 2025, up 66.5% from FY 2024.

Dividend Coverage

1.6x

RPGLIFE's free cash flow covered dividends 1.6x in FY 2025 but leaves limited surplus.

CapEx Intensity

46.3%

Capital expenditure was 46.3% of operating cash flow in FY 2025 for RPGLIFE, a moderate level of reinvestment.

2-year RPGLIFE cash flow snapshot

Hover the chart icon for YoY change.

FY 2024 - FY 2025
Item Chart 2024 2025
Net Income 1.18B 2.33B
Cash flow Operating Activities 943.60M 778.60M
Investments in PPE -692.30M -360.30M
Cash flow Investing Activities -791.50M -418.00M
Dividend Paid -198.50M -264.60M
Cash flow Financing Activities -203.10M -270.80M
Cash at beginning of period 248.20M 197.20M
Cash at end of period 197.20M 287.00M
Free Cash Flow 251.30M 418.30M

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹).

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025